Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer – the INNODIAG study

Tatiana Kempowsky-Hamon (1, 2) , Carine Valle (2) , Magali Lacroix-Triki (3, 4) , Lyamine Hedjazi (1, 2) , Lidwine Trouilh (2) , Sophie Lamarre (2) , Delphine Labourdette (2) , Laurence Roger (4) , Loubna Mhamdi (4) , Florence Dalenc (5) , Thomas Filleron (6) , Gilles Favre (4) , Jean Marie François (2, 5) , Marie-Véronique V Le Lann (1, 2) , Véronique Le Berre (2)

1 LAAS-DISCO - Équipe DIagnostic, Supervision et COnduite
2 LISBP - Laboratoire d'Ingénierie des Systèmes Biologiques et des Procédés
3 Institut Claudius Regaud
4 CRCT - Centre de Recherches en Cancérologie de Toulouse
5 Dendris SAS
6 Département d'oncologie médicale

Background : Personalized medicine has become a priority in breast cancer patient management. In addition to the routinely used clinicopathological characteristics, clinicians will have to face an increasing amount of data derived from tumor molecular profiling. The aims of this study were to develop a new gene selection method based on a fuzzy logic selection and classification algorithm, and to validate the gene signatures obtained on breast cancer patient cohorts. Methods : We analyzed data from four published gene expression datasets for breast carcinomas. We identified the best discriminating genes by comparing molecular expression profiles between histologic grade 1 and 3 tumors for each of the training datasets. The most pertinent probes were selected and used to define fuzzy molecular grade 1-like (good prognosis) and fuzzy molecular grade 3-like (poor prognosis) profiles. To evaluate the prognostic performance of the fuzzy grade signatures in breast cancer tumors, a Kaplan-Meier analysis was conducted to compare the relapse-free survival deduced from histologic grade and fuzzy molecular grade classification. Results : We applied the fuzzy logic selection on breast cancer databases and obtained four new gene signatures. Analysis in the training public sets showed good performance of these gene signatures for grade (sensitivity from 90% to 95%, specificity 67% to 93%). To validate these gene signatures, we designed probes on custom microarrays and tested them on 150 invasive breast carcinomas. Good performance was obtained with an error rate of less than 10%. For one gene signature, among 74 histologic grade 3 and 18 grade 1 tumors, 88 cases (96%) were correctly assigned. Interestingly histologic grade 2 tumors (n = 58) were split in these two molecular grade categories. Conclusion : We confirmed the use of fuzzy logic selection as a new tool to identify gene signatures with good reliability and increased classification power. This method based on artificial intelligence algorithms was successfully applied to breast cancers molecular grade classification allowing histologic grade 2 classification into grade 1 and grade 2 like to improve patients prognosis. It opens the way to further development for identification of new biomarker combinations in other applications such as prediction of treatment response.

Mots clés: Fuzzy logic; Gene signatures; Molecular grade; Breast cancer

Domaines: Sciences du Vivant [q-bio]; Biochimie, Biologie Moléculaire; Génomique, Transcriptomique et Protéomique [q-bio.GN]; Bio-Informatique, Biologie Systémique [q-bio.QM]; Cancer

Tatiana Kempowsky-Hamon, Carine Valle, Magali Lacroix-Triki, Lyamine Hedjazi, Lidwine Trouilh, et al.. Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer – the INNODIAG study. BMC Medical Genomics, 2015, 8 (3), ⟨10.1186/s12920-015-0077-1⟩. ⟨hal-01849444⟩